126 related articles for article (PubMed ID: 10396569)
1. Auditory rehabilitation in neurofibromatosis type 2: a case for cochlear implantation.
Temple RH; Axon PR; Ramsden RT; Keles N; Deger K; Yücel E
J Laryngol Otol; 1999 Feb; 113(2):161-3. PubMed ID: 10396569
[TBL] [Abstract][Full Text] [Related]
2. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
3. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
[TBL] [Abstract][Full Text] [Related]
4. Topodiagnosis of deafness: strategy for treatment of neurofibromatosis type 2.
Marangos N; Stecker M; Laszig R
J Laryngol Otol Suppl; 2000; (27):3-7. PubMed ID: 11211434
[TBL] [Abstract][Full Text] [Related]
5. Multichannel auditory brainstem implant: update on performance in 61 patients.
Otto SR; Brackmann DE; Hitselberger WE; Shannon RV; Kuchta J
J Neurosurg; 2002 Jun; 96(6):1063-71. PubMed ID: 12066908
[TBL] [Abstract][Full Text] [Related]
6. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.
Vincenti V; Pasanisi E; Guida M; Di Trapani G; Sanna M
Audiol Neurootol; 2008; 13(4):273-80. PubMed ID: 18259080
[TBL] [Abstract][Full Text] [Related]
7. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
8. The magnetless Clarion cochlear implant in a patient with neurofibromatosis 2.
Graham J; Lynch C; Weber B; Stollwerck L; Wei J; Brookes G
J Laryngol Otol; 1999 May; 113(5):458-63. PubMed ID: 10505162
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
10. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
11. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
[TBL] [Abstract][Full Text] [Related]
12. [Auditory brainstem implantation: current status and prospects].
Wu H; Jia H
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):92-96. PubMed ID: 33455123
[TBL] [Abstract][Full Text] [Related]
13. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
14. Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2.
Tran Ba Huy P; Kania R; Frachet B; Poncet C; Legac MS
Acta Otolaryngol; 2009 Sep; 129(9):971-5. PubMed ID: 19016361
[TBL] [Abstract][Full Text] [Related]
15. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
Colletti L
Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
[TBL] [Abstract][Full Text] [Related]
16. Auditory brainstem implants: current state and future directions with special reference to the subtonsillar approach for implantation.
Seki Y; Samejima N; Komatsuzaki A
Acta Neurochir Suppl; 2007; 97(Pt 2):431-5. PubMed ID: 17691332
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
18. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Auditory Brainstem Implant Surgery: A New Option for Auditory Habilitation in Congenital Deafness?
Shah PV; Kozin ED; Kaplan AB; Lee DJ
J Am Board Fam Med; 2016; 29(2):286-8. PubMed ID: 26957388
[TBL] [Abstract][Full Text] [Related]
20. Technique and indications for the French multichannel cochlear implant "Chorimac-12" for total deafness rehabilitation.
Chouard CH; Fugain C; Meyer B
Am J Otol; 1985 Jul; 6(4):291-4. PubMed ID: 3839632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
